Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Integrated clinicopathological, genomic, and immunophenotypic landscape of renal tubulocystic oncocytoma.

Frontiers in immunology - 1 Jan 2026

Wang Wenchi, Zhu Hengxing, Chen Chunyu, Sun Man, Wang Honglong, Tai Yu, Chen Sishan, Liu Zhuo, Fan Bo, Li Yinghua

Abstract excerpt

Background: Renal tubulocystic oncocytoma (RTO) is an exceptionally rare variant of renal oncocytoma (RO) with poorly understood genetic underpinnings. This study aimed to characterize the clinicopathological features and genomic landscape of RTO to enhance diagnostic precision and elucidate its molecular profile. Methods: Whole-exome sequencing (WES) was performed on a pathologically confirmed case of RTO to...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenoma, Oxyphilic
Share to Biomarkers, Tumor

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Exome Sequencing

Share to Genetic Predisposition to Disease

Share to Genomics

Share to Immunophenotyping

Share to Kidney Neoplasms

Share to Tumor Microenvironment

Source

Open in PubMed Open full text

Identifiers

PMID: 42058215
DOI: 10.3389/fimmu.2026.1728022
PMCID: PMC13120908

Genes

NEB
CD163
CD19
CD4
COL7A1
CSF3R
FBN2
FOXP3
ITK
NFATC2
NUP214
RANBP17
TCF7L2
TLR4
TSC2
ZFHX3

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Integrated clinicopathological, genomic, and immunophenotypic landscape of renal tubulocystic oncocytoma.PMID 42058215Read ↗

Evaluation of an institutional series of low-grade oncocytic tumor (LOT) of the kidney and review of the mutational landscape of LOT.Semantic proximity Read ↗

Low-grade oncocytic tumor of the kidney—a clinical, pathological, and next generation sequencing-based study of 20 tumorsSemantic proximity Read ↗

Features and molecular genetic study of low-grade oncocytic tumor of the kidney.Semantic proximity Read ↗

Distinct genomic, microenvironmental, and nephron signatures in VHL kidney cysts and tumors.Semantic proximity Read ↗

Chromophobe renal cell carcinoma: Novel molecular insights and clinicopathologic updatesSemantic proximity Read ↗

Germline and sporadic mTOR pathway mutations in low-grade oncocytic tumor of the kidney.Semantic proximity Read ↗

Molecular and histopathological insights into renal neuroendocrine tumors (RenNETs): A comprehensive study.Semantic proximity Read ↗

Update on classification of oncocytic neoplasms of the kidney.Semantic proximity Read ↗

ELOC-Mutated Renal Cell Carcinoma is a Rare Indolent Tumor With Distinctive Genomic Characteristics.Semantic proximity Read ↗

Renal tumors harboring FLCN mutations: Case series from clinical practice.Semantic proximity Read ↗

FLCN-mutated eosinophilic renal tumors: clinicopathologic and molecular analysis of five cases highlighting morphologic heterogeneity.Semantic proximity Read ↗

Low-grade oncocytic tumour of the kidney is characterised by genetic alterations of TSC1, TSC2, MTOR or PIK3CA and consistent GATA3 positivity.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.